Novus Therapeutics to Participate in Two Investor Conferences
Novus Therapeutics, Inc. is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT).
Read More
Category: US Stocks
WeedMD Changes Third Quarter 2019 Earnings Conference Call Time to 1 p.m. EST on November 29th
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets.
Read More
HEXO’s value brand Original Stash available in Ontario
Adult-use consumers in Ontario will be able to purchase 28 grams (1 oz) of quality dried cannabis flower at black market prices, retailing at $140 ($5 per gram), including taxes.
Read More
PURA – Puration Pursues $9 Billion Market With Latin American Acquisition Scheduled To Close Next Week
The closing is scheduled for next week, on Thursday, December 5, 2019. The legal Latin American cannabis market is anticipated to reach $9 billion by 2028.
Read More
KALY – Kali-Extracts Could Reach $1 Million In Total 2019 Revenue
KALY’s current revenues come primarily from the sale of CBD infused products that have utilized KALY’s U.S. Patented Cannabis Extraction Process.
Read MoreGET LISTED
